Follow us on LinkedIn - https://www.linkedin.com/company/fatty-liver-alliance/
Although there is currently no approved pharmacological treatment for fatty liver disease or NASH in North America, there may be other options for treatment. Your Physician and you together could decide the best option; diet and exercise, counselling and surgery are current treatments you could discuss.
Dr. Naim Alkouri, VP of Academic Affairs, Director of the Fatty Liver Program, Chief of Transplant Hepatology, Arizona Liver Health shares his expert insights and experience regarding the risks of NAFLD and NASH and his recommendations.
Dr. Manal Abdelmalek, Hepatologist, Professor of Medicine at Duke University discusses topics around tailored patient care, diet and exercise routines that work, and the types of specialists that could help patients who need treatment.
Dr. Giada Sebastiani presents an excellent overview of diet and best practices for patients. Let's talk about fructose!
As new treatments for fatty liver disease and NASH are being studied, the big question will be, which patients should be treated, and what will the goal of treatment be?
Dr. Mark Swain, Hepatologist, shares his views.
New treatments for NASH are in clinical trials. At the moment treating fatty liver disease is based on a "multidisciplinary team and that means we're talking to the patient directly. We’re counseling them about behavior modification, change in diet, decrease in calories, more exercise, but it also involves a dietitian and nutritionist and we often look at other components including a pharmacist...Primary Care, endocrine, cardiovascular experts, could be Cardiologists." Special thanks to Dr. Robert Gish for sharing his experience.
Will treatment of NASH be an individualized, patient centric approach? Many molecules have not made it to phase III, with only one now near possible approval. Dr. Stefano Brillanti, Hepatologist from Italy explores this question.
Clinicaltrials.gov provides patients, their family members, and the public with easy and free access to information on clinical studies for a wide range of diseases and conditions.
There are almost 500 NASH studies posted with over 100 studies currently recruiting patients, and over 200 have now been completed.